- Scotland's Kinghorn maintains Lions 'dream' despite Toulouse clash
- Pakistan debutant Ghulam hits century to defy England in second Test
- Boeing announces intention to raise up to $25 bn
- Tuchel 'in talks with FA' over England manager's job
- Dutch rider Lavreysen targets record at world track championships
- Bangladesh suspend Hathurusingha as coach after alleged assault
- Russian Olympic chief announces surprise resignation
- Ferguson to leave Man Utd ambassador role as club cuts costs
- Turkish govt defends tax plan to fund defence industry
- Oil prices tumble on easing Middle East fears
- Eidevall quits as Arsenal Women head coach
- US, Philippines launch war games after China's Taiwan drills, ship collision
- Swedish prosecutor confirms 'rape' probe without naming Mbappe
- England dismiss Ayub but Pakistan reach 173-3 at tea in second Test
- Israel vows to put 'national interest' first in response to Iran attack
- Oil prices hit by easing Middle East fears, most Asian markets rise
- Mbappe-PSG salary row faces hearing as France captain cited in 'rape' report
- K-pop star tells South Korea lawmakers of workplace bullying
- Ex-Wallabies captain Elsom denies wrongdoing after arrest warrant
- Pakistan 79-2 at lunch in second England Test after Leach strikes
- Hopes pinned on peace across Taiwan Strait after drills
- Valencia fans leave Singapore with 'stern warning' after protest
- Falling sales cause sour grapes for iconic Portugal wine
- Belgian pathologist and literary star gives 'voice to the dead'
- Ethiopia's 'korale' recyclers turn waste into money
- Italy row, AI in focus at world's biggest book fair
- US, Philippines launch war games a day after China's Taiwan drills
- Scotland lock Gray signs for Japan's Toyota
- Allen and Bills foil Rodgers, outlast Jets 23-20
- North Korea blows up roads connecting it to the South
- East Timor fights new battles 25 years after independence vote
- Japan election campaigns kick off for Oct 27 vote
- Home runs propel Mets, Yankees to MLB playoff victories
- Taiwan detects record 153 Chinese military aircraft after drills
- Oil prices drop on easing fears over Middle East, most markets rise
- Reoxygenating oceans: startups lead the way in Baltic Sea
- North Korea's Kim holds security meeting over drone flights
- Cars, chlamydia threaten Australian koalas
- Small town India's DIY film industry comes to London
- Harris slams Trump over military threat to 'enemy from within'
- Can biodiversity credits unlock billions for nature?
- Texas poised to execute autistic man for 'shaken baby' death
- King Charles III heads to Australia and Commonwealth meeting
- In the Colombian Pacific, fighting to save sharks
- Argentina's Matera banned for Italy Test after red card
- Vientos grand slam propels Mets in series-tying win over Dodgers
- Supporters of ex-Bolivia leader Morales block roads over possible arrest
- Germany into Nations League quarters, France and Italy win
- Nagelsmann lauds 'supercharged' Germany's 'best half of the year'
- 'Pandas are coming': Two new bears depart China for US capital
Fake Ozempic pens circulating in Europe, watchdogs warn
Fake injection pens of Ozempic, a hugely popular diabetes drug that went viral on social media as a way to lose weight, are circulating in Europe, drug authorities have warned.
Ozempic, which involves a once-weekly injection from a pre-filled pen, was originally developed to treat type 2 diabetes.
However since it became clear the drug was effective for weight loss, massive demand driven partly by "off label" use of the drug has led to stock shortages.
Now pre-filled pens falsely labelled as Ozempic have been identified at some wholesalers in the EU and UK, according to the European Medicines Agency (EMA).
On Sunday, France's ANSM medicines authority said that "as a precaution, we call on all players in the supply chain to be vigilant" about the fakes.
The counterfeit pens have labels in German and originated from wholesalers in Austria and Germany, the EMA said in a statement last week.
"There is no evidence that any falsified pens have been dispensed to patients from legal pharmacies and there are no reports of harm to patients in relation to the falsified medicine," the EMA said.
Police and European Union drug regulators are investigating the issue, it added.
Germany's drug regulator BfArM released a picture of the fake pens, showing that they look quite different to the official version.
The counterfeits were first noticed due to inactive serial numbers.
The active ingredient in Ozempic, semaglutide, has been approved in the EU and UK to be prescribed specifically for weight loss under the brand name Wegovy.
Both products are made by the Danish pharmaceutical group Novo Nordisk, which has seen profits soar due to demand for the drug.
Earlier this month, researchers warned that this class of drugs called GLP-1 agonists -- which also includes liraglutide drugs Rybelsus and Saxenda -- was linked to a heightened risk of certain severe gastrointestinal problems including stomach paralysis.
Although rare, the side effects show how important it is that the drugs are only taken when prescribed by doctors, the researchers emphasised.
L.Harper--AMWN